| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.009 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |